Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 326589th Legislature (2025)

Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.

Read the full bill

Progress

  1. Introduced
  2. In committee
  3. Passed one chamber Not yet
  4. Passed legislature Not yet
  5. Sent to governor Not yet
  6. Became law Not yet

What this bill would cost

Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.

Committee hearings

  1. April 9, 2025

    House Insurance Committee · Reported favorably as substituted

    Testified: 7 for, 7 against, 1 on (neutral) · Registered without testifying: 23 for, 18 against, 3 on

    Organizations for
    Texas Hospital Association, Baylor Scott and White Health, CHRISTUS Health, Central Health, Children's Hospital Association of Texas, DHR Health, and 18 more
    Organizations against
    Bristol Myers Squibb, Abbvie, BIO (Biotechnology Innovation Organization); Otsuka, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, HB Strategies, and 12 more
    Organizations on (neutral)
    Department of State Health Services, Health and Human Services Commissioner, Texas Department of Insurance, UTMB

    Official witness list

Source: Texas Legislature (Texas Legislative Council). Witness lists show how many people took each position and the organizations they represented; people speaking for themselves are counted but not named here.

Committee votes

  • House Insurance · Out of committee 5 aye, 2 nay, 2 absent

Bill analyses: House Committee Report

Legislative history

  1. House

    Committee report sent to Calendars

  2. House

    Committee report distributed

  3. House

    Comte report filed with Committee Coordinator

  4. House

    Reported favorably as substituted

  5. House

    Committee substitute considered in committee

  6. House

    Considered in formal meeting

  7. House

    Left pending in committee

  8. House

    Testimony taken/registration(s) recorded in committee

  9. House

    Considered in public hearing

  10. House

    Scheduled for public hearing on . . .

  11. House

    Referred to Insurance

  12. House

    Read first time

  13. House

    Filed